Literature DB >> 32216945

Two Patients Having NSCLC With Novel Duplication Mutation in Their EGFR Gene (p.I740_K745dupIPVAIK) and Their Response to Osimertinib.

Jiasheng Xu1, Qidi Jiang1, Hua Xu1, Anwen Liu1, Long Huang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32216945     DOI： 10.1016/j.jtho.2019.11.026

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report.

Authors:  Bin-Bin Shan; Yuan Li; Chang Zhao; Xiao-Qin An; Quan-Mao Zhang
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

Review 2.  Osimertinib-Centered Therapy Against Uncommon Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer- A Mini Review.

Authors:  Chengyang Song; Xueying Yang
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.